Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [11]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16768-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- GLT25D1 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated GLT25D1 antibody (Cat. #16768-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Molecular basis of collagen galactosylation by GLT25D1.
The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma.
The structural basis for the human procollagen lysine hydroxylation and dual-glycosylation.
COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
Lysyl hydroxylase 2 mediated collagen post-translational modifications and functional outcomes.
Cyclophilin B control of lysine post-translational modifications of skin type I collagen.
Loss of function of Colgalt1 disrupts collagen post-translational modification and causes musculoskeletal defects.
Role of Glycosyltransferase 25 Domain 1 in Type I Collagen Glycosylation and Molecular Phenotypes.
Downregulation of Glt25d1 aggravates carbon tetrachloride‑induced acute hepatic injury through activation of the TGF‑β1/Smad2 signaling pathway.
Biallelic COLGALT1 variants are associated with cerebral small vessel disease.
Ascorbate starvation alters endoplasmic reticulum-resident enzymes in cardiac fibroblasts, priming them for increased procollagen secretion.
Sun H, Zhang M, Shi Y, Zhang D, Hua Z, Yang P, Yang Y, Li J, Chen J, Wang C, Li P, Hu X, Ke Y, Zhang M, Liu X, Yu H
Nature communications 2026 Feb 6;17(1)
Nature communications 2026 Feb 6;17(1)
The collagen-modifying enzyme GLT25D1 is a prognostic indicator related to immunosuppression and malignant phenotypes in hepatocellular carcinoma.
Qiu S, Han H, Zhang H, Yang M, Wang H, Li K, Li L, Yang G
Cancer cell international 2025 Mar 8;25(1):84
Cancer cell international 2025 Mar 8;25(1):84
The structural basis for the human procollagen lysine hydroxylation and dual-glycosylation.
Peng J, Li W, Yao D, Xia Y, Wang Q, Cai Y, Li S, Cao M, Shen Y, Ma P, Liao R, Zhao J, Qin A, Cao Y
Nature communications 2025 Mar 11;16(1):2436
Nature communications 2025 Mar 11;16(1):2436
COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
Liu S, Yu Y, Wang Y, Zhu B, Han B
European journal of medical research 2022 Jul 16;27(1):122
European journal of medical research 2022 Jul 16;27(1):122
Lysyl hydroxylase 2 mediated collagen post-translational modifications and functional outcomes.
Terajima M, Taga Y, Nakamura T, Guo HF, Kayashima Y, Maeda-Smithies N, Parag-Sharma K, Kim JS, Amelio AL, Mizuno K, Kurie JM, Yamauchi M
Scientific reports 2022 Aug 22;12(1):14256
Scientific reports 2022 Aug 22;12(1):14256
Cyclophilin B control of lysine post-translational modifications of skin type I collagen.
Terajima M, Taga Y, Cabral WA, Liu Y, Nagasawa M, Sumida N, Kayashima Y, Chandrasekaran P, Han L, Maeda N, Perdivara I, Hattori S, Marini JC, Yamauchi M
PLoS genetics 2019 Jun;15(6):e1008196
PLoS genetics 2019 Jun;15(6):e1008196
Loss of function of Colgalt1 disrupts collagen post-translational modification and causes musculoskeletal defects.
Geister KA, Lopez-Jimenez AJ, Houghtaling S, Ho TH, Vanacore R, Beier DR
Disease models & mechanisms 2019 Jun 17;12(6)
Disease models & mechanisms 2019 Jun 17;12(6)
Role of Glycosyltransferase 25 Domain 1 in Type I Collagen Glycosylation and Molecular Phenotypes.
Terajima M, Taga Y, Sricholpech M, Kayashima Y, Sumida N, Maeda N, Hattori S, Yamauchi M
Biochemistry 2019 Dec 17;58(50):5040-5051
Biochemistry 2019 Dec 17;58(50):5040-5051
Downregulation of Glt25d1 aggravates carbon tetrachloride‑induced acute hepatic injury through activation of the TGF‑β1/Smad2 signaling pathway.
Ye X, He L, Ma J, Li Y, Zhang M, Yang J, Zhang J, Xiao F, Wei H
Molecular medicine reports 2018 Oct;18(4):3611-3618
Molecular medicine reports 2018 Oct;18(4):3611-3618
Biallelic COLGALT1 variants are associated with cerebral small vessel disease.
Miyatake S, Schneeberger S, Koyama N, Yokochi K, Ohmura K, Shiina M, Mori H, Koshimizu E, Imagawa E, Uchiyama Y, Mitsuhashi S, Frith MC, Fujita A, Satoh M, Taguri M, Tomono Y, Takahashi K, Doi H, Takeuchi H, Nakashima M, Mizuguchi T, Takata A, Miyake N, Saitsu H, Tanaka F, Ogata K, Hennet T, Matsumoto N
Annals of neurology 2018 Dec;84(6):843-853
Annals of neurology 2018 Dec;84(6):843-853
Ascorbate starvation alters endoplasmic reticulum-resident enzymes in cardiac fibroblasts, priming them for increased procollagen secretion.
Cowling RT, Park JI, Sotimehin AE, Greenberg BH
Journal of molecular and cellular cardiology 2017 Dec;113:1-8
Journal of molecular and cellular cardiology 2017 Dec;113:1-8
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The GLT25D1 antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human GLT25D1. This antibody recognizes human,mouse,rat antigen. The GLT25D1 antibody has been validated for the following applications: ELISA, WB analysis.
